APA (7th ed.) Citation

Verma, M., Beaulieu-Abdelahad, D., Ait-Ghezala, G., Li, R., Crawford, F., Mullan, M., & Paris, D. (2015). Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Verma, Megha, David Beaulieu-Abdelahad, Ghania Ait-Ghezala, Rena Li, Fiona Crawford, Michael Mullan, and Daniel Paris. Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD. Public Library of Science (PLoS), 2015.

MLA (9th ed.) Citation

Verma, Megha, et al. Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD. Public Library of Science (PLoS), 2015.